Clinical update on head and neck cancer: molecular biology and ongoing challenges
Head and neck squamous cell carcinomas (HNSCCs) are an aggressive, genetically
complex and difficult to treat group of cancers. In lieu of truly effective targeted therapies …
complex and difficult to treat group of cancers. In lieu of truly effective targeted therapies …
The molecular pathogenesis of head and neck squamous cell carcinoma
SM Rothenberg, LW Ellisen - The Journal of clinical …, 2012 - Am Soc Clin Investig
Squamous cell carcinoma of the head and neck (HNSCC) is a relatively common human
cancer characterized by high morbidity, high mortality, and few therapeutic options outside …
cancer characterized by high morbidity, high mortality, and few therapeutic options outside …
Common variation at 2p13. 3, 3q29, 7p13 and 17q25. 1 associated with susceptibility to pancreatic cancer
EJ Childs, E Mocci, D Campa, PM Bracci, S Gallinger… - Nature …, 2015 - nature.com
Pancreatic cancer is the fourth leading cause of cancer death in the developed world. Both
inherited high-penetrance mutations in BRCA2 (ref.), ATM, PALB2 (ref.), BRCA1 (ref.) …
inherited high-penetrance mutations in BRCA2 (ref.), ATM, PALB2 (ref.), BRCA1 (ref.) …
Compressive stress-mediated p38 activation required for ERα+ phenotype in breast cancer
PM Munne, L Martikainen, I Räty, K Bertula… - Nature …, 2021 - nature.com
Breast cancer is now globally the most frequent cancer and leading cause of women's
death. Two thirds of breast cancers express the luminal estrogen receptor-positive (ERα+) …
death. Two thirds of breast cancers express the luminal estrogen receptor-positive (ERα+) …
Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation
A highly aggressive subset of pancreatic ductal adenocarcinomas undergo trans-
differentiation into the squamous lineage during disease progression. Here, we investigated …
differentiation into the squamous lineage during disease progression. Here, we investigated …
Functional miRNAs in breast cancer drug resistance
W Hu, C Tan, Y He, G Zhang, Y Xu… - Oncotargets and …, 2018 - Taylor & Francis
Owing to improved early surveillance and advanced therapy strategies, the current death
rate due to breast cancer has decreased; nevertheless, drug resistance and relapse remain …
rate due to breast cancer has decreased; nevertheless, drug resistance and relapse remain …
microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions
H Ouyang, J Gore, S Deitz, M Korc - Oncogene, 2014 - nature.com
Abstract Increased microRNA-10b (miR-10b) expression in the cancer cells in pancreatic
ductal adenocarcinoma (PDAC) is a marker of disease aggressiveness. In the present study …
ductal adenocarcinoma (PDAC) is a marker of disease aggressiveness. In the present study …
Alterations of p63 and p73 in human cancers
K Inoue, EA Fry - Mutant p53 and MDM2 in Cancer, 2014 - Springer
Abstract p53 and its related genes, p63 and p73 constitute the p53 gene family. While p53 is
the most frequently mutated gene in human tumors, p63 and p73 are rarely mutated or …
the most frequently mutated gene in human tumors, p63 and p73 are rarely mutated or …
ΔNp63α in cancer: importance and therapeutic opportunities
ML Fisher, S Balinth, AA Mills - Trends in cell biology, 2023 - cell.com
Our understanding of cancer and the key pathways that drive cancer survival has expanded
rapidly over the past several decades. However, there are still important challenges that …
rapidly over the past several decades. However, there are still important challenges that …
ΔNp63 in squamous cell carcinoma: defining the oncogenic routes affecting epigenetic landscape and tumour microenvironment
V Gatti, C Fierro, M Annicchiarico‐Petruzzelli… - Molecular …, 2019 - Wiley Online Library
Squamous cell carcinoma (SCC) is a treatment‐refractory tumour which arises from the
epithelium of diverse anatomical sites such as oesophagus, head and neck, lung and skin …
epithelium of diverse anatomical sites such as oesophagus, head and neck, lung and skin …